Filing Details

Accession Number:
0001765581-19-000012
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-02-27 20:38:43
Reporting Period:
2019-02-25
Accepted Time:
2019-02-27 20:38:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1232524 Jazz Pharmaceuticals Plc JAZZ Pharmaceutical Preparations (2834) 981032470
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1601583 P. Matthew Young 5Th Fl, Waterloo Exchange
Waterloo Rd
Dublin 4 L2
Evp & Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Disposition 2019-02-25 1,218 $126.25 30,917 No 4 F Direct
Ordinary Shares Disposition 2019-02-26 1,032 $125.93 29,885 No 4 S Direct
Ordinary Shares Disposition 2019-02-26 1,034 $127.76 28,851 No 4 F Direct
Ordinary Shares Disposition 2019-02-27 884 $137.91 27,967 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 F Direct
No 4 S Direct
No 4 F Direct
No 4 S Direct
Footnotes
  1. Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.
  2. Includes 67 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on November 30, 2018.
  3. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.